Cancer

• Latest
• Best
• Search…

• Cancer · Mar 2015

  Erratum: Boyle EM, Fouquet G, Guidez S, Bonnet S, Demarquette H, Dulery R, Herbaux C, Noel MP, Manier S, Schraen S, Onraed B, Faucompre J-L, Hennache B, Petillon MO, Mathiot C, Avet-Loiseau H, Facon T, Harding SJ, Moreau P and Leleu X. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma. Cancer. doi: 10.1002/cncr.28946.

  Please note that Table 1 and Table 2 were mistakenly inverted. The authors regret this error.

  read more… or not…

• Cancer · Mar 2015

  Erratum: Mohty M, Malard F, Blaise D, Milpied N, Furst S, Tabrizi R, Guillaume T, Vigouroux S, El-Cheikh J, Delaunay J, Le Gouill S, Moreau P, Labopin M and Chevallier P. Reduced-toxicity conditioning with fludarabine, once-daily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: Results of a multicenter prospective phase 2 trial. Cancer. doi: 10.1002/cncr.29087.

  In Table 1, the numbers for NHL should be 20(25%). In the legend for Figure 1, part (B) should read chronic GVHD is shown. The authors regret these errors.

  read on… or just mark as read…

• Cancer · Mar 2015

  Erratum: Borderud SP, Li Y, Burkhalter JE, Sheffer CE and Ostroff JS. Electronic cigarette use among patients with cancer: Characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer. doi: 10.1002/ cncr.28811.

  The authors discovered some errors regarding reference group labels in Table 2. The corrected table is attached. The authors regret these errors.

  explore further… or just mark as read…